BSE filing, NSE: CHOKSILA. Summary written from the filing by ALFA Finder's alert engine.
Choksi Laboratories Ltd: key numbers
- Share price
- ₹196.50
- Market cap
- ₹136.9 Cr
- Revenue (annual)
- ₹46.01 Cr
- Net profit (annual)
- ₹1.96 Cr
- P/E (TTM)
- 63.3×Sector 53.4×
- Promoter holding
- 31.48%+0.00% QoQ
- FII holding
- 10.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Choksi Laboratories Ltd
All →Choksi Laboratories Business Update
Choksi Laboratories received the USFDA Establishment Inspection Report for its Indore central laboratory, closing the August 2026 inspection. No monetary penalty or fine is mentioned.
Choksi Laboratories Convertible Warrants
Choksi Laboratories' proposed convertible warrants issue was rejected at its EGM on October 17, 2026. The company requests BSE to close the in-principle approval application.
Choksi Laboratories Convertible Warrants
Choksi Laboratories' EGM on 17 Oct 2026 rejected the special resolution to allot convertible warrants to promoters. 99.46% of votes polled were against, blocking the capital raise.
Choksi Laboratories Convertible Warrants
Choksi Laboratories held an EGM regarding the issuance of convertible warrants on a preferential basis. The promoters and proposed allottees abstained from voting on the resolution.
Choksi Laboratories Other Announcement
Choksi Laboratories Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Choksi Laboratories Annual General Meeting
Choksi Laboratories Ltd has scheduled an EGM for October 17, 2026, to seek shareholder approval for issuing 3.50 lakh convertible warrants at ₹177 per warrant.
- Value
- ₹6.20 Cr
Other board meeting date announcements
All →Maharashtra Seamless Board Meeting Date
MAHARASHTRA SEAMLESS LIMITED intimated a board meeting on 13 Nov 2026 to consider unaudited standalone and consolidated quarterly and half-year results for September 2026, plus other business. Trading window closes 15 Nov 2026.
Duropack Board Meeting Date
DUROPACK LIMITED intimated a board meeting on 14 Nov 2026 to consider unaudited standalone quarterly results for September 2026. Trading window closes 17 Nov 2026.
Goel Food Products Board Meeting Date
GOEL FOOD PRODUCTS LIMITED intimated a board meeting on 13 Nov 2026 to consider unaudited standalone half-yearly results for September 2026. Trading window closes 15 Nov 2026.
Cerebra Integrated Technologies Board Meeting Date
Cerebra Integrated Technologies Limited intimated a board meeting on 12 Nov 2026 to consider unaudited standalone and consolidated quarterly results for September 2026. Trading window closes 16 Nov 2026.
RSD Finance Board Meeting Date
RSD Finance Ltd intimated a board meeting on 13 Nov 2026 to consider unaudited standalone and consolidated half-yearly results for September 2026. Trading window closes 15 Nov 2026.
Xtglobal Infotech Board Meeting Date
XTGLOBAL INFOTECH Limited intimated a board meeting on 13 Nov 2026 to consider unaudited standalone and consolidated half-yearly results for September 2026, plus ESOP and other business. Trading window closes 15 Nov 2026.